Notably, however, in chronic kidney disease, when EPO production is restricted due to kidney damage, haemoglobin levels are higher for higher BMI [31] and lower EPO doses are required to maintain haemoglobin levels in obese compared to normal weight patients [32–34]. The gene discussed is EPO; the disease is chronic kidney disease.